HaplnScience, Inc. was selected as 'Top Biotech Start up' in APAC by StartupCity, the journal of global start up industry.

In the linked article, StartupCity introduced HaplnScience as the innovative Korean biopharma company that develops a breakthrough anti-aging therapy and valuated HaplnScience's leading pipeline, HS-101, as a promising candidate for DMOAD (Disease Modifying Osteoarthritis Drug).

Link:
https://biotech-apac.startupcity.com/vendor/haplnscience-a-breakthrough-in-modern-antiaging-therapies--cid-545-mid-57.html